US2015322451A1PendingUtilityA1
Tobacco having altered leaf properties and methods of making and using
Est. expiryApr 8, 2034(~7.7 yrs left)· nominal 20-yr term from priority
A24D 3/043A24B 13/00C12N 15/8243C12N 15/8218A24D 1/00C12N 15/8261A24F 47/008A24F 40/20
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure provides tobacco plants containing a PMT RNAi and tobacco plants having a mutation in PMT, and methods of making and using such plants.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of making a Nicotiana tabacum plant, comprising:
inducing mutagenesis in N. tabacum cells to produce mutagenized N. tabacum cells; obtaining one or more N. tabacum plants from the mutagenized N. tabacum cells; and identifying at least one of the N. tabacum plants that comprises a mutated PMT sequence.
2 . The method of claim 1 , further comprising identifying at least one of the N. tabacum plants that exhibits reduced amounts of nicotine relative to a N. tabacum plant lacking a mutated PMT.
3 . The method of claim 1 , further comprising identifying at least one of the N. tabacum plants that, when material from the at least one plant is cured, exhibits a reduced amount of at least one TSNA relative to cured material from a N. tabacum plant lacking a mutated PMT.
4 . The method of claim 1 , wherein leaf from the mutant N. tabacum plant exhibits comparable or better quality than leaf from the plant lacking a mutated PMT sequence.
5 . The method of claim 1 , wherein the N. tabacum plant is a Burley type, a dark type, a flue-cured type, or an Oriental type.
6 . A variety of Nicotiana tabacum , the variety comprising plants having a mutation in an endogenous nucleic acid, the wild type endogenous nucleic acid encoding the PMT sequence shown in SEQ ID NO:2, 4, 6, 8 or 10.
7 . The variety of claim 6 , wherein leaf from the mutant plants exhibits a reduced amount of nicotine relative to leaf from a plant lacking the mutation.
8 . The variety of claim 6 , wherein material from the mutant plants, when cured, exhibits a reduced amount of at least one TSNA relative to cured material from a plant lacking the mutation.
9 . The variety of claim 6 , wherein leaf from the mutant N. tabacum plant exhibits comparable or better quality than leaf from the plant lacking a mutated PMT sequence.
10 . Cured leaf from the N. tabacum variety of claim 6 .
11 . A tobacco product comprising the cured leaf of claim 10 .
12 . The tobacco product of claim 11 , selected from the group consisting of cigarettes, smokeless tobacco products, tobacco-derived nicotine products, cigarillos, non-ventilated recess filter cigarettes, vented recess filter cigarettes, cigars, snuff, electronic cigarettes, e-vapor products, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, and cut tobacco.
13 . A RNA nucleic acid molecule comprising a first nucleic acid between 15 and 500 nucleotides in length and a second nucleic acid between 15 and 500 nucleotides in length, wherein the first nucleic acid has a region of complementarity to the second nucleic acid, wherein the first nucleic acid comprises at least 15 contiguous nucleotides of the sequence shown in SEQ ID NO:1, 3, 5, 7 or 9.
14 . The nucleic acid molecule of claim 13 , further comprising a spacer nucleic acid between the first nucleic acid and the second nucleic acid.
15 . A method of making a Nicotiana tabacum plant, comprising:
transforming N. tabacum cells with the nucleic acid molecule of claim 13 to produce transgenic N. tabacum cells; regenerating transgenic N. tabacum plants from the transgenic N. tabacum cells; and selecting at least one transgenic N. tabacum plant that comprises the nucleic acid molecule or the construct.
16 . The method of claim 15 , further comprising identifying at least one transgenic N. tabacum plant having reduced amount of nicotine relative to a N. tabacum plant not transformed with the nucleic acid molecule.
17 . The method of claim 15 , further comprising identifying at least one transgenic N. tabacum plant that, when material from the at least one transgenic N. tabacum plant is cured, exhibits a reduced amount of at least one TSNA relative to cured material from a N. tabacum plant not transformed with the nucleic acid molecule.
18 . The method of claim 15 , wherein leaf from the selected transgenic N. tabacum plant exhibits comparable or better quality than leaf from the non-transformed N. tabacum plant.
19 . A transgenic Nicotiana tabacum plant comprising a vector, the vector comprising a RNA nucleic acid molecule having a length of 15 to 500 nucleotides and having at least 95% sequence identity to a PMT nucleic acid shown in SEQ ID NO:1, 3, 5, 7 or 9.
20 . The transgenic N. tabacum plant of claim 19 , wherein the plant exhibits reduced amount of nicotine in the leaf relative to leaf from a N. tabacum plant lacking the nucleic acid molecule.
21 . The transgenic N. tabacum plant of claim 19 , wherein, when material from the at least one transgenic N. tabacum plant is cured, exhibits a reduced amount of at least one TSNA relative to cured material from a N. tabacum plant lacking the nucleic acid molecule.
22 . The transgenic N. tabacum plant of claim 19 , wherein leaf from the plant exhibits comparable or better quality than leaf from a N. tabacum plant lacking the nucleic acid molecule.
23 . Cured leaf from the transgenic N. tabacum plant of claim 19 .
24 . A tobacco product comprising the cured leaf of claim 23 .
25 . The tobacco product of claim 24 , selected from the group consisting of smokeless tobacco products, tobacco-derived nicotine products, cigarillos, non-ventilated recess filter cigarettes, vented recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, and cut tobacco.Join the waitlist — get patent alerts
Track US2015322451A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.